Health economics in the field of osteoarthritis: An Experts consensus paper from the European society for clinical and economic aspects of Osteoporosis and Osteoarthritis
| Autor: | Daniel Pinto, Stuart G. Silverman, Mickaël Hiligsmann, Tore K Kvien, Johan Severens, Jean-Pierre Pelletier, John A. Kanis, Francis Guillemin, Maria Luisa Brandi, Nigel K Arden, David J. Hunter, Lucio C. Rovati, Marc C. Hochberg, Maarten Boers, Andrea Laslop, Olivier Bruyère, Yannis Tsouderos, Jaime Branco, René Rizzoli, S. Reiter-Niesert, Cyrus Cooper, Peter Tugwell, Jean-Yves Reginster |
|---|---|
| Přispěvatelé: | Health Economics (HE), Epidemiology and Data Science, Rheumatology, CCA - Quality of life, Health Services Research, RS: CAPHRI School for Public Health and Primary Care |
| Jazyk: | angličtina |
| Rok vydání: | 2013 |
| Předmět: |
Gerontology
medicine.medical_specialty Consensus Cost effectiveness Cost-Benefit Analysis Population Alternative medicine review Disease methods Quality of life (healthcare) Cost of Illness Rheumatology Epidemiology Humans Medicine education cost-effectiveness education.field_of_study Cost-utility Evidence-Based Medicine Health economics business.industry cost–utility Cost-effectiveness analysis economics osteoarthritis Anesthesiology and Pain Medicine ddc:618.97 Quality of Life Physical therapy arthroplasty business |
| Zdroj: | Seminars in Arthritis and Rheumatism, 43(3), 303-313. W.B. Saunders Seminars in Arthritis and Rheumatism, 43(3), 303-313. W.B. Saunders Ltd Seminars in Arthritis and Rheumatism, 43(3), 303-313. W B Saunders Co-Elsevier Inc Seminars in Arthritis and Rheumatism, Vol. 43, No 3 (2013) pp. 303-313 Hiligsmann, M, Cooper, C, Arden, N, Boers, M, Branco, J C, Brandi, M L, Bruyere, O, Guillemin, F, Hochberg, M C, Hunter, D J, Kanis, J A, Kvien, T K, Laslop, A, Pelletier, J P, Pinto, D, Reiter-Niesert, S, Rizzoli, R, Rovati, L C, Severens, J L H, Silverman, S, Tsouderos, Y, Tugwell, P & Reginster, J Y 2013, ' Health economics in the field of osteoarthritis: An Expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) ', Seminars in Arthritis and Rheumatism, vol. 43, no. 3, pp. 303-313 . https://doi.org/10.1016/j.semarthrit.2013.07.003 |
| ISSN: | 1532-866X 0049-0172 |
| DOI: | 10.1016/j.semarthrit.2013.07.003 |
| Popis: | OBJECTIVES: There is an important need to evaluate therapeutic approaches for osteoarthritis (OA) in terms of cost-effectiveness as well as efficacy. METHODS: The ESCEO expert working group met to discuss the epidemiological and economic evidence that justifies the increasing concern of the impact of this disease and reviewed the current state-of-the-art in health economic studies in this field. RESULTS: OA is a debilitating disease; it is increasing in frequency and is associated with a substantial and growing burden on society, in terms of both burden of illness and cost of illness. Economic evaluations in this field are relatively rare, and those that do exist, show considerable heterogeneity of methodological approach (such as indicated population, comparator, decision context and perspective, time horizon, modeling and outcome measures used). This heterogeneity makes comparisons between studies problematic. CONCLUSIONS: Better adherence to guidelines for economic evaluations is needed. There was strong support for the definition of a reference case and for what might constitute "standard optimal care" in terms of best clinical practice, for the control arms of interventional studies. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Full Text from ScienceDirect